Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 19/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 18/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 11/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5655986 | 0.78 | PTGS2 (0.44) | PTGS2PTGS1ALOX5 | |
| SCHEMBL7563291 | 0.73 | PTGS2 (0.38) | PTGS2PTGS1ALOX5 | |
| SCHEMBL6153136 | 0.72 | PTGS2 (0.43) | PTGS2PTGS1ALOX5 | |
| SCHEMBL5656078 | 0.72 | PTGS2 (0.47) | PTGS2PTGS1ALOX5 | |
| SCHEMBL7562425 | 0.72 | PTGS1 (0.32) | PTGS2PTGS1ALOX5 | |
| SCHEMBL7568295 | 0.72 | PTGS2 (0.41) | PTGS2PTGS1ALOX5 | |
| SCHEMBL25181143 | 0.72 | PTGS2 (0.36) | PTGS2PTGS1ALOX5 | |
| SCHEMBL13668257 | 0.71 | PTGS1 (0.31) | PTGS2PTGS1 | |
| SCHEMBL7564521 | 0.71 | PTGS2 (0.34) | PTGS2PTGS1ALOX5 | |
| SCHEMBL2489432 | 0.70 | AHR (0.38) | PTGS2PTGS1ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1228055-A1 | DIHYDROAMINOBENZO[B]- AND [C]FURANS AS RETINOID-LIKE AGENTS | Allergan Sales, Inc. (US) | 2002-08-07 | — | — | EP | disclosed |
| WO-2001012618-A1 | DIHYDROAMINOBENZO[B]- AND [C]FURANS AS RETINOID-LIKE AGENTS | ALLERGAN SALES, INC. (US) | 2001-02-22 | — | — | WO | disclosed |
| US-6093838-A | FOR TREATING SKIN-RELATED DISEASES, INCLUDING ACTINIC KERATOSES, ARSENIC KERATOSES, ECZEMA | ALLERGAN SALES, INC. (US) | 2000-07-25 | — | — | US | disclosed |